Radiomics models to predict bone marrow metastasis of neuroblastoma using CT
Open Access
- 28 June 2024
- journal article
- research article
- Published by Wiley in Cancer Innovation
- Vol. 3 (5) , e135
Abstract
Background: Bone marrow is the leading site for metastasis from neuroblastoma and affects the prognosis of patients with neuroblastoma. However, the accurate diagnosis of bone marrow metastasis is limited by the high spatial and temporal heterogeneity of neuroblastoma. Radiomics analysis has been applied in various cancers to build accurate diagnostic models but has not yet been applied to bone marrow metastasis of neuroblastoma.Methods: We retrospectively collected information from 187 patients pathologically diagnosed with neuroblastoma and divided them into training and validation sets in a ratio of 7:3. A total of 2632 radiomics features were retrieved from venous and arterial phases of contrast‐enhanced computed tomography (CT), and nine machine learning approaches were used to build radiomics models, including multilayer perceptron (MLP), extreme gradient boosting, and random forest. We also constructed radiomics‐clinical models that combined radiomics features with clinical predictors such as age, gender, ascites, and lymph gland metastasis. The performance of the models was evaluated with receiver operating characteristics (ROC) curves, calibration curves, and risk decile plots.Results: The MLP radiomics model yielded an area under the ROC curve (AUC) of 0.97 (95% confidence interval [CI]: 0.95–0.99) on the training set and 0.90 (95% CI: 0.82–0.95) on the validation set. The radiomics‐clinical model using an MLP yielded an AUC of 0.93 (95% CI: 0.89–0.96) on the training set and 0.91 (95% CI: 0.85–0.97) on the validation set.Conclusions: MLP‐based radiomics and radiomics‐clinical models can precisely predict bone marrow metastasis in patients with neuroblastoma.Keywords
Funding Information
- National Natural Science Foundation of China (82103544, 82202251)
This publication has 34 references indexed in Scilit:
- High-Risk Neuroblastoma Treatment ReviewChildren, 2018
- Correlation of CT signs with lymphatic metastasis and pathology of neuroblastoma in childrenOncology Letters, 2018
- Computational Radiomics System to Decode the Radiographic PhenotypeCancer Research, 2017
- Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trialsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- NeuroblastomaNature Reviews Disease Primers, 2016
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- NeuroblastomaAdvances in Pediatrics, 2011
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceBritish Journal of Cancer, 2009
- Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk NeuroblastomaJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009